The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXps Pensions Regulatory News (XPS)

Share Price Information for Xps Pensions (XPS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 248.00
Bid: 254.00
Ask: 257.00
Change: -7.00 (-2.75%)
Spread: 3.00 (1.181%)
Open: 259.00
High: 259.00
Low: 248.00
Prev. Close: 255.00
XPS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of General Meeting held on 7 March 2024

7 Mar 2024 15:54

RNS Number : 0553G
XPS Pensions Group PLC
07 March 2024
 

XPS Pensions Group plc

7 March 2024

 

XPS Pensions Group plc

 

Results of General Meeting held on 7 March 2024

 

XPS Pensions Group plc (the 'Company') announces that at its General Meeting ('GM') held on 7 March 2024, the resolution put to shareholders was passed by the requisite majority. The resolution was passed as an ordinary resolution. The result of the poll taken on the resolution, on which Equiniti, the Company's registrar, acted as scrutineer, is as follows:

 

Resolution

Votes For

%

Votes Against

%

Total Votes

% of issued

share capital voted

1

Approve Directors' Remuneration Policy 2024

131,060,632

 

76.44

 

40,386,688

 

23.56

 

171,447,320

 

82.61%

 

 

As at 12.00pm on Thursday 7 March 2024, the number of issued shares in the Company was 207,544,975 ordinary shares, which was the total number of shares entitling the holders to attend and vote for or against all the resolutions at the GM. In accordance with the Company's Articles of Association, on a poll every member present in person or by proxy has one vote for every share held.

 

There were no restrictions on shareholders to cast votes on any of the resolutions proposed at the GM. Votes withheld are not votes in law and therefore have not been counted in the calculation of the proportion of the votes for or against a resolution.

 

Full details of the resolution passed, together with explanatory notes, are set out in the Notice of General Meeting which is available at www.xpsgroup.com.

 

At the Company's 2023 Annual General Meeting (the 'AGM'), there was strong support for the Directors' Remuneration Report reflecting the application of the 2020 Directors' Remuneration Policy. As announced on 5 September 2023, resolution 4 (the approval of the Directors' Remuneration Policy 2023) was withdrawn ahead of the AGM, to enable the Committee to engage further with shareholders. The Remuneration Committee have since undertaken an extensive consultation with the Company's 20 largest shareholders, covering c.85% of the Company's issued share capital, and key proxy advisory firms. An updated policy was approved at the GM today. This policy is effectively a continuation of the previously approved policy, introducing an element of bonus deferral in line with evolving market practice, reflecting that the overwhelming majority of shareholders consulted felt that the existing policy was appropriate. The Board acknowledges that 19.46% of the Group's total issued share capital was voted against the resolution and recognises that a small number of shareholders have differing views. The Board would like to thank those shareholders that have participated in consultation and will continue to engage as appropriate in the future.

 

Following the AGM in September, during which resolutions 5 (the re-election of Alan Bannatyne, Chairman) and 11 (the re-election of Margaret Snowdon, Non-Executive Director and Remuneration Committee Chair) received below 80% support, the Company has appointed two additional Independent Non-Executive Directors and continued to engage with shareholders regarding Board composition. The Board also notes that the Company complies with all aspects of the UK Corporate Governance Code.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMEDLFBZXLEBBF
Date   Source Headline
11th Apr 20247:00 amRNSPost-close trading update
10th Apr 202411:18 amRNSStandard form for notification of major holdings
8th Apr 20249:04 amRNSTR-1: Standard form for notification of holdings
20th Mar 202410:41 amRNSStandard form for notification of major holdings
19th Mar 20241:32 pmRNSHolding(s) in Company
7th Mar 20243:54 pmRNSResults of General Meeting held on 7 March 2024
6th Mar 20242:10 pmRNSHolding(s) in Company
6th Mar 202410:15 amRNSHolding(s) in Company
23rd Feb 20247:22 amRNSListing Rule 9.6.14(2) Disclosure
22nd Feb 202410:22 amRNSHolding(s) in Company
15th Feb 20247:00 amRNSTrading update and Notice of General Meeting
7th Feb 202411:14 amRNSDirector/PDMR Shareholding
18th Jan 20243:12 pmRNSBlock Listing Six Monthly Return
13th Dec 20234:49 pmRNSDirector/PDMR Shareholding
13th Dec 20233:13 pmRNSDirector/PDMR Shareholding
7th Dec 20237:00 amRNSNon-Executive Director Appointments
5th Dec 202310:28 amRNSHolding(s) in Company
24th Nov 20237:00 amRNSInvestor Presentation
23rd Nov 20237:00 amRNSHalf-year Report
21st Nov 20237:00 amRNSXPS completes the sale of NPT to SEI
13th Nov 20239:00 amRNSXPS appointed to provide services to John Lewis
23rd Oct 20233:58 pmRNSHolding(s) in Company
19th Oct 202312:12 pmRNSDirector/PDMR Shareholding
17th Oct 20237:00 amRNSPost-close trading update
13th Oct 202312:50 pmRNSNotice of Trading Update
9th Oct 20236:22 pmRNSHolding(s) in Company Replacement
9th Oct 20234:53 pmRNSHolding(s) in Company
7th Sep 20233:30 pmRNSResults of Annual General Meeting
5th Sep 20239:54 amRNSAGM Update
1st Sep 20232:13 pmRNSHolding(s) in Company
1st Sep 20232:10 pmRNSTotal Voting Rights and Share Capital
25th Aug 20233:33 pmRNSDirector/PDMR Shareholding
26th Jul 20234:01 pmRNSDirector/PDMR Shareholding
26th Jul 20237:10 amRNSChairman directorship notification
21st Jul 202311:30 amRNSInvestor Presentation
20th Jul 202310:53 amRNSDirector/PDMR Shareholding
18th Jul 20239:30 amRNSBlock listing Interim Review
17th Jul 20237:00 amRNSDirector/PDMR Shareholding
14th Jul 20234:45 pmRNSDirector/PDMR Shareholding
14th Jul 20237:00 amRNSNPT Strategic Partnership with SEI
13th Jul 20239:23 amRNSAnnual Report & Accounts 2022/23 and Notice of AGM
4th Jul 202311:20 amRNSDirector/PDMR Shareholding
26th Jun 202312:29 pmRNSHolding(s) in Company
23rd Jun 20234:01 pmRNSStatement re: press speculation
22nd Jun 20237:00 amRNSFinal Results
13th Jun 20235:01 pmRNSHolding(s) in Company
1st Jun 20233:27 pmRNSHolding(s) in Company
24th May 20237:00 amRNSCapital Markets Event & Post-close trading update
22nd Mar 20237:00 amRNSPre-close trading update
21st Feb 20237:00 amRNSNon-Executive Director Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.